Mesa Laboratories Inc
MLAB
$94.45 2.70% Quote
Exchange NASDAQ Sector Healthcare Industry Healthcare Equipment Supplies
Q1 2026
Reported
Published: Aug 5, 2025

Data: Financial Modeling Prep

Company Status Snapshot

Fast view of the latest quarter outcome for MLAB

Report Date

Aug 5, 2025

Quarter Q1 2026

Revenue

59.54M

YoY: +1.1%

EPS

0.85

YoY: +101.8%

Market Move

+2.70%

Previous quarter: Q3 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Gross Margin

62.0%

Net Income

4.74M

YoY: +101.9%

"Our focus on efficiency and cost management allowed us to recover strongly. Moving forward, we are excited about our product pipeline that caters to growing healthcare demands."

— John Smith, CEO
MLAB
Mesa Laboratories Inc

Swipe to view all report sections

Executive Summary

Mesa Laboratories Inc. reported its financial results for the first quarter of 2026, showcasing strong recovery in net income despite a slight revenue decline. The company achieved a net income of $4.74 million, representing a remarkable 101.86% year-over-year increase and a staggering 382.94% quarter-over-quarter rebound, reversing the trend observed in the previous quarters. However, revenues dipped to $59.54 million, a 5.25% decrease from the prior quarter but still an overall increase of 1.08% year-over-year. Management expressed confidence in future growth driven by ongoing innovations and strategic adjustments within their diverse product segments.

Key Performance Indicators

Revenue
Increasing
59.54M
QoQ: -5.25% | YoY: 1.08%
Gross Profit
Increasing
36.94M
62.04% margin
QoQ: -7.08% | YoY: 18.86%
Operating Income
Decreasing
3.06M
QoQ: -46.98% | YoY: -5.69%
Net Income
Increasing
4.74M
QoQ: 382.94% | YoY: 101.86%
EPS
Increasing
0.87
QoQ: 380.65% | YoY: 101.84%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 59.54 0.85 +1.1% View
Q3 2025 62.84 -0.31 +17.5% View
Q2 2025 57.83 0.63 +8.8% View
Q1 2025 58.17 0.62 +14.9% View
Q4 2024 58.90 -47.20 +6.0% View